Keywords: iolab, livostin, approved, usa, johnson, unit, levocabastine

IOLAB'S LIVOSTIN APPROVED IN USA

Article | 22 November 1993

Print This

Johnson & Johnson unit Iolab's Livostin (levocabastine) ophthalmic suspension has been approved in the USA for the temporary relief of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in